OPCH vs. LHCG, CHE, AMED, BTSG, ADUS, AHCO, AVAH, EHAB, ALGN, and TEVA
Should you be buying Option Care Health stock or one of its competitors? The main competitors of Option Care Health include LHC Group (LHCG), Chemed (CHE), Amedisys (AMED), BrightSpring Health Services (BTSG), Addus HomeCare (ADUS), AdaptHealth (AHCO), Aveanna Healthcare (AVAH), Enhabit (EHAB), Align Technology (ALGN), and Teva Pharmaceutical Industries (TEVA). These companies are all part of the "medical" sector.
LHC Group (NASDAQ:LHCG) and Option Care Health (NASDAQ:OPCH) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, institutional ownership, dividends, valuation, media sentiment, earnings, risk, analyst recommendations and profitability.
Option Care Health has a net margin of 6.15% compared to Option Care Health's net margin of 2.73%. LHC Group's return on equity of 18.92% beat Option Care Health's return on equity.
LHC Group received 336 more outperform votes than Option Care Health when rated by MarketBeat users. Likewise, 59.04% of users gave LHC Group an outperform vote while only 58.97% of users gave Option Care Health an outperform vote.
In the previous week, Option Care Health had 6 more articles in the media than LHC Group. MarketBeat recorded 6 mentions for Option Care Health and 0 mentions for LHC Group. LHC Group's average media sentiment score of 0.95 beat Option Care Health's score of 0.22 indicating that Option Care Health is being referred to more favorably in the news media.
83.5% of LHC Group shares are owned by institutional investors. Comparatively, 98.1% of Option Care Health shares are owned by institutional investors. 4.8% of LHC Group shares are owned by insiders. Comparatively, 0.6% of Option Care Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Option Care Health has higher revenue and earnings than LHC Group. Option Care Health is trading at a lower price-to-earnings ratio than LHC Group, indicating that it is currently the more affordable of the two stocks.
Option Care Health has a consensus target price of $40.00, suggesting a potential upside of 34.14%. Given LHC Group's higher probable upside, analysts plainly believe Option Care Health is more favorable than LHC Group.
LHC Group has a beta of 0.43, suggesting that its share price is 57% less volatile than the S&P 500. Comparatively, Option Care Health has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500.
Summary
Option Care Health beats LHC Group on 11 of the 17 factors compared between the two stocks.
Get Option Care Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for OPCH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OPCH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Option Care Health Competitors List
Related Companies and Tools
